TY - JOUR
T1 - Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension
AU - Ofori-Anyinam, Boatema
AU - Riley, Abi Janet
AU - Jobarteh, Tijan
AU - Gitteh, Ensa
AU - Sarr, Binta
AU - Faal-Jawara, Tutty Isatou
AU - Rigouts, Leen
AU - Senghore, Madikay
AU - Kehinde, Aderemi
AU - Onyejepu, Nneka
AU - Antonio, Martin
AU - de Jong, Bouke C
AU - Gehre, Florian
AU - Meehan, Conor J
N1 - OGOA; FTX; (CC BY-NC-ND 4.0); Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The geographically restricted Mycobacterium africanum lineages (MAF) are primarily found in West Africa, where they account for a significant proportion of tuberculosis. Despite this phenomenon, little is known about the co-evolution of these ancient lineages with West Africans. MAF and M. tuberculosis sensu stricto lineages (MTB) differ in their clinical, in vitro and in vivo characteristics for reasons not fully understood. Therefore, we compared genomes of 289 MAF and 205 MTB clinical isolates from the 6 main human-adapted M. tuberculosis complex lineages, for mutations in their Electron Transport Chain and Central Carbon Metabolic pathway in order to explain these metabolic differences. Furthermore, we determined, in silico, whether each mutation could affect the function of genes encoding enzymes in these pathways. We found more mutations with the potential to affect enzymes in these pathways in MAF lineages compared to MTB lineages. We also found that similar mutations occurred in these pathways between MAF and some MTB lineages. Generally, our findings show further differences between MAF and MTB lineages that may have contributed to the MAF clinical and growth phenotype and indicate potential adaptation of MAF lineages to a distinct ecological niche, which we suggest includes areas characterized by low oxygen tension.
AB - The geographically restricted Mycobacterium africanum lineages (MAF) are primarily found in West Africa, where they account for a significant proportion of tuberculosis. Despite this phenomenon, little is known about the co-evolution of these ancient lineages with West Africans. MAF and M. tuberculosis sensu stricto lineages (MTB) differ in their clinical, in vitro and in vivo characteristics for reasons not fully understood. Therefore, we compared genomes of 289 MAF and 205 MTB clinical isolates from the 6 main human-adapted M. tuberculosis complex lineages, for mutations in their Electron Transport Chain and Central Carbon Metabolic pathway in order to explain these metabolic differences. Furthermore, we determined, in silico, whether each mutation could affect the function of genes encoding enzymes in these pathways. We found more mutations with the potential to affect enzymes in these pathways in MAF lineages compared to MTB lineages. We also found that similar mutations occurred in these pathways between MAF and some MTB lineages. Generally, our findings show further differences between MAF and MTB lineages that may have contributed to the MAF clinical and growth phenotype and indicate potential adaptation of MAF lineages to a distinct ecological niche, which we suggest includes areas characterized by low oxygen tension.
U2 - 10.1016/j.tube.2020.101899
DO - 10.1016/j.tube.2020.101899
M3 - A1: Web of Science-article
C2 - 32090860
SN - 1472-9792
VL - 120
JO - Tuberculosis
JF - Tuberculosis
M1 - 101899
ER -